https://www.marketscreener.com/quote/stock/TRAWS-PHARMA-INC-46372025/news/Onconova-Therapeutics-Preclinical-Narazaciclib-Data-At-SABCS-Highlights-Differentiated-Anti-Tumor-Ac-45542496/?utm_source=telegram&utm_medium=social&utm_campaign=share